Phenoxazine derivatives inactivate human cytomegalovirus, herpes simplex virus-1, and herpes simplex virus-2 in vitro

Journal of Pharmacological Sciences

Volumn 106, Issue 3, 2008, Pages 369-375

  Hayashi, Kyoko ^a   Hayashi, Toshimitsu ^a   Tomoda, Akio ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Herpes simplex virus type 1; Herpes simplex virus type 2; Human cytomegalovirus; Phenoxazine

Indexed keywords

2 AMINO 4,4ALPHA DIHYDRO 4ALPHA 7 DIMETHYL 3H PHENOXAZIN 3 ONE; 2 AMINO PHENOXAZIN 3 ONE; 3 AMINO 1,4ALPHA DIHYDRO 4ALPHA 8 DIMETHYL 2H PHENOXAZIN 2 ONE; GANCICLOVIR; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG INHIBITION; EXPERIMENTAL STUDY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; INFECTION COMPLICATION; NONHUMAN; TIME; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; VIRUS INHIBITION;

EID: 41549102457     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071679     Document Type: Article

References (29)

1. Sinzger C, Jahan G. Human cytomegalovirus cell tropism and pathogenesis. Intervirolgy. 1996;39:302-319.
2. Weller TH. The cytomegaloviruses: uniquitous agents with protean clinical manifestations. II. N Engl J Med. 1971;285:267-274.
3. Odeberg J, Wolmer N, Westgren M, Seiger A, Soderberg-Naucler C. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol. 2006;80:8929-8939.
4. Elion G. Mechanism of action of antiviral selectivity of acyclovir. Am J Med. 1982;73:7-13.
5. Faulds D, Heal RC. Gansiclovir. A review of the antiviral activity, pharmacolinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs. 1990;39:597-638.
6. Tang J, Colacino JM, Larsen SH, Spizer W. Virucidal activity of hypericin against enveloped and non-enveloped DNA and RNA viruses. Antiviral Res. 1990;13:313-326.
7. Andersen DO, Weber ND, Wood SG, Hughes B, Murray BK, North JA. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res. 1991;16:185-196.
8. Huang HC, Chu SH, Chao PDL. Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur J Pharmacol. 1991;198:211-213.
9. Koshibu-Koizumi J, Akazawa M, Iwamoto T, Takasaki M, Mizuno F, Kobayashi R, et al. Antitumor activity of a phenoxazine compound, 2-amino-4,4α- dihydro-4α-7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: Induction of mixed types of cell death, apoptosis and necrosis. Cancer Res Clin Oncol. 2002;128:363-368.
10. Kato S, Shirato K, Imaizumi K, Toyota M, Mizuguchi J, Odawara M, et al. Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep. 2006;15:843-848.
11. Shirato K, Imaizumi K, Abe A, Tomoda A. Phenoxazine derivatives, 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one and 2-amino-phenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell lien NB-1 cells. Biol Pharm Bull. 2007;30:331-336.
12. Shirato K, Imaizumi K, Abe A, Tomoda A. Phenoxazine derivatives induce caspase-independent cell death in human glioblastoma cell lines, A-172 and U-251 MG. Oncol Rep. 2007;17:201-208.
13. Uruma T, Yamaguchi H, Fukuda M, Goto H, Kishimoto T, Yamamoto Y, et al. Chlamydia pneumoniae growth inhibition in human monocyte THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative. J Med Microbiol. 2005;54:1143-1149.
14. Shimizu S, Suzuki M, Tomoda A, Arai S, Taguchi H, Hanawa T, et al. Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med. 2004;203:47-52.
15. + induced contraction of smooth muscles in rat aorta and guinea pig tenia cecum. Biol Pharm Bull. 2005;28:1521-1523.
16. Enoki E, Sada K, Qu X, Kyo S, Shahjahan Miah SM, Hatani T, et al. The phenoxazine derivative Phx-1 suppresses IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells. J Pharmacol Sci. 2004;94:329-333.
17. Iwata A, Yamaguchi T, Sato K, Yoshitake N, Tomoda A. Suppression of proliferation of poliovirus and porcine parvovirus by novel phenoxazines, 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one and 3-amino-1,4α-dihydro-4α-8-dimethyl-2H-phenoxazine-2-one. Biol Pharm Bull. 2005;28:905-907.
18. Tomoda A, Arai S, Ishida R, Shimamoto T, Ohyashiki K. An improved method for the rapid preparation of 2-amino-4,4α-dihydro-4α-7-dimethyl-3H- phenoxazine-3-one, a novel anti-tumor agent. Biorg Med Chem Lett. 2002;11:1057-1058.
19. Lee JB, Hayashi K, Hirata M, Kuroda E, Suzuki E, Hayashi T. Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama bay. Biol Pharm Bull. 2006;29:2135-2139.
20. Hayashi K, Mori J, Saito H, Hayashi T. Antiviral targets of a Chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus. Biol Pharm Bull. 2006;29:1843-1847.
21. Penfold ME, Mocarski ES. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virol. 1997;239:46-61.
22. Mori H, Honda K, Ishida R, Nohira T, Tomoda A. Antitumor activity of 2-amino-4,4α-dihydro-4α-7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anticancer Drug. 2000;11:653-657.
23. Shimamoto T, Tomoda A, Ishida R, Ohyashiki K. Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin Cancer Res. 2001;704:704-708.
24. Miyano-Kurosaki N, Kurosaki K, Hayashi M, Takaku H, Hayafune M, Shirato K, et al. 2-Aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice. Biol Pharm Bul. 2006;29:2197-2201.
25. Boyland E. The biochemistry of cancer of bladder. Br Med Bull. 1958;14:153-158.
26. Hendrich AB, Stanczak K, Momorowska M, Motohashi N, Kawase M, Michalak K. A study on the perturbation of model lipid membranes by phenoxazines. Biorg Med Chem. 2006;14:5948-5954.
27. Stinski MF. Sequence of protein synthesis in cells infected by human cytomegalovirus: entry and late virus-induced polypeptides. J Virol. 1978;26:686-701.
28. Azuine MA, Tokuda H, Takayasu J, Enjyo F, Mukainaka T, Konoshima T, et al. Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models. Pharmacol Res. 2004;49:161-169.
29. Jarvis MA, Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol. 2002;5:403-407.